Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study

Endocrine ◽  
2012 ◽  
Vol 42 (2) ◽  
pp. 366-374 ◽  
Author(s):  
Christoph Beglinger ◽  
Ke Hu ◽  
Ying Wang ◽  
Emmanuel Bouillaud ◽  
Christelle Darstein ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Healthy Male ◽  
Double Blind ◽  
Once Daily ◽  
Double Blind Placebo ◽  
Healthy Male Volunteers ◽  
Male Volunteers

Multiple Rising Doses of Oral BI 1358894 in Healthy Male Volunteers: A Phase I Study to Investigate Safety and Tolerability

2020 ◽  
Vol 87 (9) ◽  
pp. S417-S418
Author(s):  
Markus Goettel ◽  
Lena Herich ◽  
Sabrina Wiebe ◽  
Rene Fuertig ◽  
Vikas Sharma ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Healthy Male ◽  
Healthy Male Volunteers ◽  
Male Volunteers

A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers

1998 ◽  
Vol 176 (6) ◽  
pp. 27S-31S ◽  
Author(s):  
Claartje H.M van Nispen ◽  
Andy I.M Hoepelman ◽  
Marja Rozenberg-Arska ◽  
Jan Verhoef ◽  
Lynn Purkins ◽  
...  
Keyword(s):  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Parallel Group Study ◽  
Parallel Group

A phase I study to determine the effect of tamoxifen on the pharmacokinetics of a single 250 mg oral dose of gefitinib (IRESSA) in healthy male volunteers

2005 ◽  
Vol 56 (6) ◽  
pp. 557-562 ◽  
Author(s):  
Mireille V. Cantarini ◽  
Merran P. Macpherson ◽  
Anna L. Marshall ◽  
Anna V. Robinson ◽  
Christopher J. Bailey
Keyword(s):  
Oral Dose ◽  
Phase I ◽  
Phase I Study ◽  
Healthy Male ◽  
Healthy Male Volunteers ◽  
Male Volunteers
Sign in / Sign up

Export Citation Format

Share Document